Drug Type Chemical drugs, Diagnostic radiopharmaceuticals |
Synonyms |
Target |
Mechanism TAU inhibitors(Microtubule-associated protein tau inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | - | Aprinoia Therapeutics, Inc.Startup | - |
Alzheimer Disease | Phase 2 | - | - | |
Nerve Degeneration | Phase 2 | - | Aprinoia Therapeutics, Inc.Startup | - |
Nerve Degeneration | Phase 2 | - | - |